- Creating next generation treatments & cures
- Delivering value to patients & our economy
Sr. Scientist DevOps,
CompanyName
Chief Maketing Officer,
CompanyName
Chief Pitier of Fools,
CompanyName
David Thomas, CFA
Senior Director of Industry Research, BIO
David is currently Senior Director of Industry Research and Analysis at BIO in Washington, DC. In this role, he is responsible for financial statistics and analysis of the biotechnology sector and contributes to BIO’s policy activities as well as programming for BIO’s investor conferences. Prior to joining BIO, he was a research scientist at the J. Craig Venter Institute working on the “synthetic cell” team led by Nobel Laureate Hamilton Smith. Before his role in synthetic biology, David worked as a scientist in drug discovery at Amgen, Millennium, and Novartis. His scientific expertise is in protein engineering, enzymology, and synthetic biology. David has earned the Chartered Financial Analyst (CFA) designation and holds a master’s degree in biochemistry
Use this section to add content in a Full-Width column
Fill out the form to request your copy of this important BIO report.
Includes:
Report Highlights
More than 90% of our industry is made up of small companies. This report captures stats for companies with less than a $1 billion in sales and covers six main areas: venture funding, public investment (IPOs and follow-ons), licensing, M&A, and the clinical pipeline (partnered vs. partnered).
David Thomas, CFA
Senior Director of Industry Research, BIO
David is currently Senior Director of Industry Research and Analysis at BIO in Washington, DC. In this role, he is responsible for financial statistics and analysis of the biotechnology sector and contributes to BIO’s policy activities as well as programming for BIO’s investor conferences. Prior to joining BIO, he was a research scientist at the J. Craig Venter Institute working on the “synthetic cell” team led by Nobel Laureate Hamilton Smith. Before his role in synthetic biology, David worked as a scientist in drug discovery at Amgen, Millennium, and Novartis. His scientific expertise is in protein engineering, enzymology, and synthetic biology. David has earned the Chartered Financial Analyst (CFA) designation and holds a master’s degree in biochemistry.
Add a description, link, or some more info here...
Add a description, link, or some more info here...
Add a description, link, or some more info here...
Add a description, link, or some more info here...
4-Column Code Box [Resource]
This content spans 12 columns, but the row below is broken up into 1/4 columns for an easy copy/paste into any other editable area
1st Column
2nd Column
3rd Column
4th Column